Educational Impact of A Clinical Advances Curriculum On EGFR Exon 20 Insertion Mutated NSCLC And EGFR TKI-Resistant NSCLC

被引：0
|
作者：
Dorkhom, N. V. [1 ]
Cannon, M. [2 ]
Cohen, J. [3 ]
机构：
[1] Medscape, Naarden, Netherlands
[2] Medscape, Paris, France
[3] Medscape, New York, NY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Continuing Medical Education; EGFR exon 20 insertion mutations; EGFR TKI resistance;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-13
引用
收藏
页码：S645 / S645
页数：1
相关论文
共 50 条
  • [31] The clinical utility of longitudinal measurement of mutated EGFR in plasma of advanced NSCLC patients during EGFR-TKI treatment
    Szpechcinski, A.
    Bryl, M.
    Wojda, E.
    Czyzewicz, G.
    Swiniuch, D.
    Szwiec, M.
    Ramlau, R.
    Sliwinski, P.
    Barinow-Wojewodzki, A.
    Chorostowska-Wynimko, J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [32] Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity
    Elamin, Yasir Y.
    Robichaux, Jacqulyne P.
    Carter, Brett W.
    Altan, Mehmet
    Tran, Hai
    Gibbons, Don L.
    Heeke, Simon
    Fossella, Frank, V
    Lam, Vincent K.
    Le, Xiuning
    Negrao, Marcelo, V
    Nilsson, Monique B.
    Patel, Anisha
    Vijayan, R. S. K.
    Cross, Jason B.
    Zhang, Jianjun
    Byers, Lauren A.
    Lu, Charles
    Cascone, Tina
    Feng, Lei
    Luthra, Rajyalakshmi
    San Lucas, Francis A.
    Mantha, Geeta
    Routbort, Mark
    Blumenschein, George, Jr.
    Tsao, Anne S.
    Heymach, John, V
    CANCER CELL, 2022, 40 (07) : 754 - +
  • [33] T regulatory type 1 (Tr1) cells, a potential target in EGFR TKI-resistant NSCLC
    Guo, H.
    Han, R.
    Zhou, F.
    Zhou, C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S562 - S562
  • [34] MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells
    Presutti, Dario
    Santini, Simonetta
    Cardinali, Beatrice
    Papoff, Giuliana
    Lalli, Cristiana
    Samperna, Simone
    Fustaino, Valentina
    Giannini, Giuseppe
    Ruberti, Giovina
    PLOS ONE, 2015, 10 (11):
  • [35] A Large Asian Real-World EGFR exon 20Insertion Mutated NSCLC Dataset with Deep Genomic Characterization
    Tan, A. C.
    Lai, G. G. Y.
    Saw, S. P. L.
    Pang, M.
    Yeo, J. C.
    Alvarez, J.
    Skanderup, A. J.
    Lim, K. H.
    Takano, A.
    Tan, G. S.
    Tan, W. C.
    Chan, J. W. K.
    Teh, Y. L.
    Rajasekaran, T.
    Jain, A.
    Tan, W. L.
    Ng, Q. S.
    Kanesvaran, R.
    Lim, W. T.
    Tan, E. H.
    Ang, M. K.
    Tan, D. S. W.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S330 - S330
  • [36] Clinical efficacy analysis of furmonertinib and structural insights into sensitivity to diverse TKIs for NSCLC with EGFR exon 20 insertion
    Zhang, Xiao
    Feng, Guoxing
    Liu, Baoxing
    Han, Huan
    Dong, Bosheng
    Yang, Yanfang
    Zhu, Hui
    Wang, Huijuan
    Fan, Saijun
    Tang, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] Treatment Patterns and Clinical Outcomes among Advanced NSCLC Patients with EGFR exon 20 Insertion Mutations in China
    Wang, Y.
    Lin, H. M.
    Ning, N.
    Du, F.
    Gao, X.
    Dong, Q.
    Yang, G.
    Xu, H.
    He, Y.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S609 - S609
  • [38] Amivantamab is effective in NSCLC harbouring EGFR exon 20 insertions
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (10) : 604 - 604
  • [39] Amivantamab is effective in NSCLC harbouring EGFR exon 20 insertions
    Diana Romero
    Nature Reviews Clinical Oncology, 2021, 18 : 604 - 604
  • [40] Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
    Zhou, Caicun
    Tang, Ke-Jing
    Cho, Byoung Chul
    Liu, Baogang
    Paz-Ares, Luis
    Cheng, Susanna
    Kitazono, Satoru
    Thiagarajan, Muthukkumaran
    Goldman, Jonathan W.
    Sabari, Joshua K.
    Sanborn, Rachel E.
    Mansfield, Aaron S.
    Hung, Jen-Yu
    Boyer, Michael
    Popat, Sanjay
    Mourao Dias, Josiane
    Felip, Enriqueta
    Majem, Margarita
    Gumus, Mahmut
    Kim, Sang-we
    Ono, Akira
    Xie, John
    Bhattacharya, Archan
    Agrawal, Trishala
    Shreeve, S. Martin
    Knoblauch, Roland E.
    Park, Keunchil
    Girard, Nicolas
    PAPILLON Investigators
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (22): : 2039 - 2051
12345